Collegium Pharmaceutical
COLL
COLL
178 hedge funds and large institutions have $843M invested in Collegium Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 63 increasing their positions, 70 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% less funds holding
Funds holding: 198 → 178 (-20)
56% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 36
91% less call options, than puts
Call options by funds: $122K | Put options by funds: $1.29M
Holders
178
Holding in Top 10
3
Calls
$122K
Puts
$1.29M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$7.24M | |
| 3 | +$5.72M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$4.43M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$3.24M |
Top Sellers
| 1 | -$6.53M | |
| 2 | -$5.23M | |
| 3 | -$4.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$4.34M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$3.88M |